Last update 25 Jan 2025

Megestrol Acetate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione, 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate, 17alpha-Acetoxy-6-dehydro-6-methylprogesterone
+ [36]
Target
Mechanism
PR agonists(Progesterone receptor agonists)
Inactive Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (US)
Login to view timeline

Structure/Sequence

Molecular FormulaC24H32O4
InChIKeyRQZAXGRLVPAYTJ-GQFGMJRRSA-N
CAS Registry595-33-5

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Acquired Immunodeficiency Syndrome
US
18 Aug 1971
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Squamous Cell Carcinoma of Head and NeckPhase 3
CN
01 Jan 2025
DementiaPhase 3
ES
01 Jun 2007
NeoplasmsPhase 3
US
01 Jun 2006
AnorexiaPhase 3
US
31 Aug 2001
CachexiaPhase 3
US
31 Aug 2001
Pulmonary Disease, Chronic ObstructivePhase 2
ES
01 Oct 2006
HIV Wasting SyndromePhase 2
US
01 Dec 2004
HIV Wasting SyndromePhase 2
IN
01 Dec 2004
HIV Wasting SyndromePhase 2
ZA
01 Dec 2004
MalnutritionPhase 2
US
31 Aug 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
oliejipjdw(fikzykkobt) = hipybqpaql ncjbzhwmwd (yqrasxbpyi )
-
01 Jun 2024
Not Applicable
-
cdkxdxpawo(ukkfbvmczb) = ddejktvpvn usckddsdph (bsiilmcrii )
-
24 May 2024
Not Applicable
-
nrbfdosedp(oxizrddmjg) = exggpurlha eqkfqdrxoe (bimlbfwnqo )
-
05 Oct 2023
iuhdmdeabo(omqwpehnyj) = kgodswjqqv ebzffvcwak (guoghcjwjt )
Phase 2
20
Megestrol-Acetate (MA)
prltzmysmb(xvwkhjrasn) = fjitfhlxht iavdysakjc (rpzbzkjjbc )
Negative
12 May 2023
Another Hormone Therapy (AHT)
prltzmysmb(xvwkhjrasn) = ajfaibqdec iavdysakjc (rpzbzkjjbc )
Not Applicable
Endometrial Carcinoma
estrogen receptor | progesterone receptors
83
Tamoxifen-progestin combination therapy
mhrenbjasx(beeiiwpwin) = vvzptrecow nrafpsdspk (zikuedvcrp )
Positive
20 Oct 2022
Progestin-only therapy
mhrenbjasx(beeiiwpwin) = lwhtzkawln nrafpsdspk (zikuedvcrp )
Phase 2/3
180
MA+LNG-IUS
gfrlodayyc(rqnggmlubz) = LNG-IUS group had lower incidence of abdominal pain iwoiruuhae (mwyoseugwh )
Positive
01 Nov 2021
MA
Phase 2
150
(Megestrol Acetate and Metformin)
uufdxrifxw(rkmhxgnyzg) = rsdhljtgkh zqbqvbcagt (qhstiiplqh, vyjasfzdek - ybluzsahxb)
-
13 Sep 2021
(Megestrol Acetate)
uufdxrifxw(rkmhxgnyzg) = tnugsmlsxp zqbqvbcagt (qhstiiplqh, rmkbbdadup - yhgvdnmdyo)
Not Applicable
-
Megestrol Acetate (MA)
efynqzdpag(aromdlxelw) = qydndznpgd hsevkndxzj (imftevegai )
Positive
03 May 2021
Phase 2
9
Quality-of-Life Assessment+megestrol acetate
(Regimen 1 (Megestrol Acetate, Surgery))
bhqqlbscqr(gamnykktmk) = deetlkwkor crqlnmawbn (llshezecui, ahhchlmfuj - dwmxyuhbmr)
-
14 Oct 2020
Quality-of-Life Assessment+megestrol acetate
(Regimen 2 (Megestrol Acetate, Surgery))
bhqqlbscqr(gamnykktmk) = sawswntbfr crqlnmawbn (llshezecui, zqjgesjqem - nfmxtnctjf)
Not Applicable
-
1
gxwlgprrda(lqlxqyoujp) = nuohpbknzw cxzoiayuju (eneqsmzjca )
-
08 May 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free